University of Bergen
uib.noTotal trials
140
Active
22
Phase 3
2
Total enrollment
178,952
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| covid-19 vaccine | — | — | — | — | — | 1 | |
| FLUENZ | — | — | — | — | — | 1 |
Next readouts
- 2024-12-12
- 2025-12-31
Top conditions
- Healthy6
- Dementia6
- Obesity5
- Pain5
- Depression4
- Overweight3
- Sleep3
- Anxiety3
Frequently asked questions about University of Bergen
- How many clinical trials does University of Bergen have on ClinicalTrials.gov?
- University of Bergen is listed as the lead sponsor on 140 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Bergen's trials are in Phase 3?
- 2 of University of Bergen's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does University of Bergen focus on?
- University of Bergen's most-studied conditions on ClinicalTrials.gov are Healthy, Dementia, Obesity, Pain, Depression.
- When are University of Bergen's next clinical trial readouts?
- University of Bergen has 2 upcoming primary-completion readouts tracked here; the soonest is “Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination”, expected around 2024-12-12.